PAI-1 (Plasminogen Activator Inhibitor-1) Expression Renders Alternatively Activated Human Macrophages Proteolytically Quiescent

被引:25
|
作者
Hohensinner, Philipp J. [1 ]
Baumgartner, Johanna [1 ]
Kral-Pointner, Julia B. [2 ]
Uhrin, Pavel [2 ]
Ebenbauer, Benjamin [1 ]
Thaler, Barbara [1 ]
Doberer, Konstantin [1 ]
Stojkovic, Stefan [1 ]
Demyanets, Svitlana [1 ,3 ]
Fischer, Michael B. [4 ,6 ]
Huber, Kurt [7 ,8 ]
Schabbauer, Gernot [2 ]
Speidl, Walter S. [1 ]
Wojta, Johann [1 ,5 ,8 ]
机构
[1] Med Univ Vienna, Dept Internal Med 2, Div Cardiol, Waehringer Guertel 18-20, A-1090 Vienna, Austria
[2] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Vasc Biol & Thrombosis Res, Vienna, Austria
[3] Med Univ Vienna, Dept Lab Med, Vienna, Austria
[4] Med Univ Vienna, Clin Blood Grp Serol & Transfus Med, Vienna, Austria
[5] Med Univ Vienna, Core Facil, Vienna, Austria
[6] Danube Univ Krems, Dept Hlth Sci & Biomed, Krems An der Donau, Austria
[7] Wilhelminenspital Stadt Wien, Dept Med 3, Vienna, Austria
[8] Ludwig Boltzmann Cluster Cardiovasc Res, Vienna, Austria
基金
奥地利科学基金会;
关键词
arteriosclerosis; macrophages; matrix metalloproteinases; serine proteases; serpins; HUMAN CARDIAC-CELLS; MATRIX METALLOPROTEINASES; MONONUCLEAR PHAGOCYTES; ENDOTHELIAL-CELLS; TISSUE-REPAIR; KAPPA-B; POLARIZATION; FIBROSIS; ATHEROSCLEROSIS; MONOCYTE;
D O I
10.1161/ATVBAHA.117.309383
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-Macrophages are versatile immune cells capable of polarizing into functional subsets depending on environmental stimulation. In atherosclerotic lesions, proinflammatory polarized macrophages are associated with symptomatic plaques, whereas Th2 (T-helper cell type 2) cytokine-polarized macrophages are inversely related with disease progression. To establish a functional cause for these observations, we analyzed extracellular matrix degradation phenotypes in polarized macrophages. Approach and Results-We provide evidence that proinflammatory polarized macrophages rely on membrane-bound proteases including MMP-14 (matrix metalloproteinase-14) and the serine protease uPA (urokinase plasminogen activator) together with its receptor uPAR for extracellular matrix degradation. In contrast, Th2 cytokine alternatively primed macrophages do not show different proteolytic activity in comparison to unpolarized macrophages and lack increased localization of MMP-14 and uPA receptor to the cell membrane. Nonetheless, they express the highest amount of the serine protease uPA. However, uPA activity is blocked by similarly increased expression of its inhibitor PAI-1 (plasminogen activator inhibitor 1). When inhibiting PAI-1 or when analyzing macrophages deficient in PAI1, Th2 cytokine-polarized macrophages display the same matrix degradation capability as proinflammatory-primed macrophages. Within atherosclerotic lesions, macrophages positive for the alternative activation marker CD206 express high levels of PAI-1. In addition, to test changed tissue remodeling capacities of alternatively activated macrophages, we used a bleomycin lung injury model in mice reconstituted with PAI-1(-/-) bone marrow. These results supported an enhanced remodeling phenotype displayed by increased fibrosis and elevated MMP activity in the lung after PAI-1 loss. Conclusions-We were able to demonstrate matrix degradation dependent on membrane-bound proteases in proinflammatory stimulated macrophages and a forced proteolytical quiescence in alternatively polarized macrophages by the expression of PAI-1. Visual Overview-An online visual overview is available for this article.
引用
收藏
页码:1913 / +
页数:22
相关论文
共 50 条
  • [21] PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) EXPRESSION PROMOTES FIBROTIC RENAL TUBULAR DYSFUNCTION
    Lian, Fei
    Tang, Jiaqi
    Arnouk, Alex
    Samarakoon, Rohan
    Higgins, Paul
    JOURNAL OF UROLOGY, 2018, 199 (04): : E115 - E115
  • [22] REACTIVATION OF LATENT PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) INVIVO
    VAUGHAN, DE
    DECLERCK, PJ
    VANHOUTTE, E
    DEMOL, M
    COLLEN, D
    CIRCULATION, 1990, 82 (04) : 601 - 601
  • [23] Inhibition of plasminogen activator inhibitor-1 (PAI-1) promotes adipocyte differentiation
    Liang, XB
    Declerck, PJ
    Wasserman, DH
    Fogo, AB
    Ma, LY
    DIABETES, 2005, 54 : A444 - A444
  • [24] DAYTIME FLUCTUATIONS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) IN POPULATIONS WITH HIGH PAI-1 LEVELS
    JUHANVAGUE, I
    ALESSI, MC
    RACCAH, D
    AILLAUD, MF
    BILLEREY, M
    ANSALDI, J
    PHILIPJOET, C
    VAGUE, P
    THROMBOSIS AND HAEMOSTASIS, 1992, 67 (01) : 76 - 82
  • [25] Plasminogen activator inhibitor-1 (PAI-1) is anti-fibrogenic in human inflammatory cardiomyopathy
    Baumeier, C.
    Escher, F.
    Pietsch, H.
    Aleshcheva, G.
    Schultheiss, H. P.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1729 - 1729
  • [26] Plasminogen activator inhibitor-1 (PAI-1) - pathogenetic role in coronary disease
    Mlynarska, Agata
    Waszyrowski, Tomasz
    Kasprzak, Jaroslaw D.
    KARDIOLOGIA POLSKA, 2007, 65 (09) : 1109 - 1114
  • [27] PURIFICATION AND CHARACTERIZATION OF NATURAL AND RECOMBINANT HUMAN-PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)
    ALESSI, MC
    DECLERCK, PJ
    DEMOL, M
    NELLES, L
    COLLEN, D
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1988, 175 (03): : 531 - 540
  • [28] Inactivation of plasminogen activator inhibitor-1 (PAI-1) by XR5118
    Faint, R
    Charlton, P
    Templeton, D
    Bent, F
    Folkes, A
    Mackie, I
    Machin, S
    Bevan, P
    BLOOD, 1996, 88 (10) : 1121 - 1121
  • [29] REACTIVATION OF LATENT PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) INVIVO
    VAUGHAN, DE
    DECLERCK, PJ
    VANHOUTTE, E
    DEMOL, M
    COLLEN, D
    ARTERIOSCLEROSIS, 1990, 10 (05): : A909 - A909
  • [30] Is plasminogen activator inhibitor-1 (PAI-1) a surrogate marker of vascular damage?
    Montoro-Garcia, Silvia
    Marin, Francisco
    Roldan, Vanessa
    Lip, Gregory Y. H.
    THROMBOSIS RESEARCH, 2011, 128 (06) : 601 - 602